Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndrome

ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations

2000 • 4,662 citations

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

2000 • 3,097 citations

ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article

2002 • 2,599 citations

Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events

2003 • 2,140 citations

Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation

2000 • 942 citations

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2002 • 895 citations

Silent Ischemia as a Marker for Early Unfavorable Outcomes in Patients with Unstable Angina

1986 • 680 citations

Prognostic Value of the Admission Electrocardiogram in Acute Coronary Syndromes

1999 • 554 citations

TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE‐ACS

2005 • 514 citations

The Electrocardiogram Predicts One-Year Outcome of Patients With Unstable Angina and Non–Q Wave Myocardial Infarction: Results of the TIMI III Registry ECG Ancillary Study fn1fn1The TIMI III Clinical Centers are supported by Grant R01-HL42311 and the Data Coordinating Center by Grant R01-HL42428 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Additional support was supplied by Genentech, Inc., South San Francisco, California.

1997 • 357 citations

Silent Myocardial Ischemia

2003 • 320 citations

Acute Coronary Syndromes in the GUSTO-IIb Trial

1998 • 259 citations

ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome

1989 • 221 citations

Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide

2003 • 206 citations

ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease. The FRISC II ECG substudy

2002 • 135 citations

Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression

1999 • 124 citations

In-Hospital Revascularization and One-Year Outcome of Acute Coronary Syndrome Patients Stratified by the GRACE Risk Score

2005 • 117 citations

Clinical trial–derived risk model may not generalize to real-world patients with acute coronary syndrome

2004 • 96 citations

Long-term prognosis in unstable angina. The importance of early risk stratification using continuous ST segment monitoring

1998 • 78 citations

Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients

2001 • 77 citations

Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina

1997 • 64 citations

ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease

2002 • 62 citations

Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring

1999 • 59 citations

Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy

2000 • 56 citations

The combination of a continuous 12-lead ECG and troponin T. A valuable tool for risk stratification during the first 6 hours in patients with chest pain and a non-diagnostic ECG

2000 • 53 citations

Pathophysiology and prognostic significance of holter-detected ST segment depression after myocardial infarction

1992 • 52 citations

Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease

1999 • 49 citations

Transient ischaemia refractory to conventional medical treatment in unstable angina: angiographic correlates and prognostic implications

1992 • 40 citations

Unstable angina: Role of silent ischemia and total ischemic time (silent plus painful ischemia), a 6-year follow-up

1992 • 38 citations

Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial

2006 • 34 citations

Non-invasive risk stratification within 48 h of hospital admission in patients with unstable coronary disease

1997 • 31 citations

Clinical Utility of Serial and Continuous ST-Segment Recovery Assessment in Patients With Acute ST-Elevation Myocardial Infarction

2004 • 28 citations

Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring

2004 • 23 citations

[Long-term prognosis in unstable angina].

1995 • 22 citations

Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment

2002 • 20 citations

Why is recurrent myocardial ischaemia a predictor of adverse outcome in unstable angina?. An observational study of myocardial ischaemia and its relation to coronary anatomy

2001 • 16 citations

The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: The Enoxaparin in Non–Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy

2006 • 8 citations